iTeos Therapeutics ITOS
$ 8.84
0.34%
Quarterly report 2024-Q2
added 08-08-2024
iTeos Therapeutics Income Statement 2011-2024 | ITOS
Annual Income Statement iTeos Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
421 M | 555 M | 1.64 B | 779 M | - | - | - | - | - | - | - | - | - |
Shares |
35.8 M | 35.6 M | 35.2 M | 24.3 M | - | - | - | - | - | - | - | - | - |
Historical Prices |
11.8 | 15.6 | 46.6 | 33.8 | - | - | - | - | - | - | - | - | - |
Net Income |
-113 M | 96.7 M | 215 M | -38 M | -22.5 M | -18.1 M | - | - | - | - | - | - | - |
Revenue |
12.6 M | 268 M | 345 M | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-151 M | 126 M | 245 M | -45.2 M | -28 M | - | - | - | - | - | - | - | - |
Interest Expense |
4.08 M | 7.79 M | 1.3 M | -48 K | -85 K | - | - | - | - | - | - | - | - |
EBITDA |
-150 M | 127 M | 246 M | -38.8 M | -22.7 M | -17.3 M | - | - | - | - | - | - | - |
Operating Expenses |
164 M | 141 M | 99.9 M | 39.3 M | 23.3 M | 17.8 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
50.4 M | 43.9 M | 40.5 M | 15.3 M | 8.84 M | 4.31 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement iTeos Therapeutics
2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
39.7 M | 35.8 M | 35.8 M | 35.8 M | 35.7 M | 35.6 M | 35.6 M | 35.5 M | 35.5 M | 35.5 M | 35.2 M | 35.1 M | 35.1 M | 35 M | 24.3 M | 349 K | 257 K | 257 K | 186 K | 186 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-7.13 M | - | -32.2 M | -34.3 M | -15.6 M | - | 991 K | 5.63 M | 69.6 M | - | 69.6 M | -26.5 M | -13.5 M | - | -10.7 M | -7.2 M | -5.25 M | - | -6.92 M | -5.76 M | -4.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
35 M | - | - | - | 12.6 M | - | 19.5 M | 41.7 M | 153 M | - | 104 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-14.2 M | - | -43.3 M | -42.6 M | -24.9 M | - | -15.2 M | 3.34 M | 121 M | - | 79.4 M | -29.3 M | -18.7 M | - | -13.5 M | -8.53 M | -8.24 M | - | -7.7 M | -6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
67 K | - | 771 K | 326 K | 1.65 M | - | 9.28 M | 3.61 M | -2.12 M | - | -8.48 M | 60 K | 240 K | - | 265 K | 12 K | -42 K | - | -2 K | -47 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-13.9 M | - | -43.1 M | -42.4 M | -24.7 M | - | -15 M | 3.54 M | 121 M | - | 79.6 M | -29.1 M | -18.6 M | - | -13.4 M | -8.43 M | -8.12 M | - | -7.23 M | -5.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
49.2 M | - | 43.3 M | 42.6 M | 37.5 M | - | 34.7 M | 38.4 M | 31.7 M | - | 24.9 M | 29.3 M | 18.7 M | - | 13.5 M | 8.53 M | 8.24 M | - | 7.7 M | 6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
12.5 M | - | 12.6 M | 13.4 M | 11.9 M | - | 10.8 M | 11.5 M | 10.6 M | - | 8.76 M | 15.1 M | 7.05 M | - | 4.8 M | 2.39 M | 2.42 M | - | 2.7 M | 2.09 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency